204 related articles for article (PubMed ID: 21294544)
1. G-quadruplex-binding benzo[a]phenoxazines down-regulate c-KIT expression in human gastric carcinoma cells.
McLuckie KI; Waller ZA; Sanders DA; Alves D; Rodriguez R; Dash J; McKenzie GJ; Venkitaraman AR; Balasubramanian S
J Am Chem Soc; 2011 Mar; 133(8):2658-63. PubMed ID: 21294544
[TBL] [Abstract][Full Text] [Related]
2. Targeting Canine
Zorzan E; Da Ros S; Giantin M; Shahidian LZ; Guerra G; Palumbo M; Sissi C; Dacasto M
J Pharmacol Exp Ther; 2018 Dec; 367(3):461-472. PubMed ID: 30275152
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of 7-substituted-5,6-dihydrobenzo[c]acridine derivatives as new c-KIT promoter G-quadruplex binding ligands.
Guo QL; Su HF; Wang N; Liao SR; Lu YT; Ou TM; Tan JH; Li D; Huang ZS
Eur J Med Chem; 2017 Apr; 130():458-471. PubMed ID: 28284084
[TBL] [Abstract][Full Text] [Related]
4. A dihydroindolizino indole derivative selectively stabilizes G-quadruplex DNA and down-regulates c-MYC expression in human cancer cells.
Nagesh N; Raju G; Srinivas R; Ramesh P; Reddy MD; Reddy ChR
Biochim Biophys Acta; 2015 Jan; 1850(1):129-40. PubMed ID: 25452213
[TBL] [Abstract][Full Text] [Related]
5. Porphyrin binding mechanism is altered by protonation at the loops in G-quadruplex DNA formed near the transcriptional activation site of the human c-kit gene.
Manaye S; Eritja R; Aviñó A; Jaumot J; Gargallo R
Biochim Biophys Acta; 2012 Dec; 1820(12):1987-96. PubMed ID: 23000573
[TBL] [Abstract][Full Text] [Related]
6. Screening of candidate G-quadruplex ligands for the human c-KIT promotorial region and their effects in multiple in-vitro models.
Zorzan E; Da Ros S; Musetti C; Shahidian LZ; Coelho NF; Bonsembiante F; Létard S; Gelain ME; Palumbo M; Dubreuil P; Giantin M; Sissi C; Dacasto M
Oncotarget; 2016 Apr; 7(16):21658-75. PubMed ID: 26942875
[TBL] [Abstract][Full Text] [Related]
7. Targeting promoter G-quadruplex DNAs by indenopyrimidine-based ligands.
Diveshkumar KV; Sakrikar S; Harikrishna S; Dhamodharan V; Pradeepkumar PI
ChemMedChem; 2014 Dec; 9(12):2754-65. PubMed ID: 25359695
[TBL] [Abstract][Full Text] [Related]
8. A small molecule that disrupts G-quadruplex DNA structure and enhances gene expression.
Waller ZA; Sewitz SA; Hsu ST; Balasubramanian S
J Am Chem Soc; 2009 Sep; 131(35):12628-33. PubMed ID: 19689109
[TBL] [Abstract][Full Text] [Related]
9. Stabilization of c-KIT G-Quadruplex DNA Structures by the RNA Polymerase I Inhibitors BMH-21 and BA-41.
Mazzini S; Gargallo R; Musso L; De Santis F; Aviñó A; Scaglioni L; Eritja R; Di Nicola M; Zunino F; Amatulli A; Dallavalle S
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31590335
[TBL] [Abstract][Full Text] [Related]
10. A non-canonical DNA structure is a binding motif for the transcription factor SP1 in vitro.
Raiber EA; Kranaster R; Lam E; Nikan M; Balasubramanian S
Nucleic Acids Res; 2012 Feb; 40(4):1499-508. PubMed ID: 22021377
[TBL] [Abstract][Full Text] [Related]
11. An in silico investigation of the binding modes and pathway of APTO-253 on c-KIT G-quadruplex DNA.
Pal S; Paul S
Phys Chem Chem Phys; 2021 Feb; 23(5):3361-3376. PubMed ID: 33502401
[TBL] [Abstract][Full Text] [Related]
12. A conserved quadruplex motif located in a transcription activation site of the human c-kit oncogene.
Fernando H; Reszka AP; Huppert J; Ladame S; Rankin S; Venkitaraman AR; Neidle S; Balasubramanian S
Biochemistry; 2006 Jun; 45(25):7854-60. PubMed ID: 16784237
[TBL] [Abstract][Full Text] [Related]
13. Putative DNA quadruplex formation within the human c-kit oncogene.
Rankin S; Reszka AP; Huppert J; Zloh M; Parkinson GN; Todd AK; Ladame S; Balasubramanian S; Neidle S
J Am Chem Soc; 2005 Aug; 127(30):10584-9. PubMed ID: 16045346
[TBL] [Abstract][Full Text] [Related]
14. G-Quadruplex Modulation of SP1 Functional Binding Sites at the
Da Ros S; Nicoletto G; Rigo R; Ceschi S; Zorzan E; Dacasto M; Giantin M; Sissi C
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396937
[TBL] [Abstract][Full Text] [Related]
15. Binding of quinazolinones to c-KIT G-quadruplex; an interplay between hydrogen bonding and π-π stacking.
Moghaddam KG; de Vries AH; Marrink SJ; Faraji S
Biophys Chem; 2019 Oct; 253():106220. PubMed ID: 31302375
[TBL] [Abstract][Full Text] [Related]
16. Structure of an unprecedented G-quadruplex scaffold in the human c-kit promoter.
Phan AT; Kuryavyi V; Burge S; Neidle S; Patel DJ
J Am Chem Soc; 2007 Apr; 129(14):4386-92. PubMed ID: 17362008
[TBL] [Abstract][Full Text] [Related]
17. Topology specific stabilization of promoter over telomeric G-quadruplex DNAs by bisbenzimidazole carboxamide derivatives.
Dhamodharan V; Harikrishna S; Bhasikuttan AC; Pradeepkumar PI
ACS Chem Biol; 2015 Mar; 10(3):821-33. PubMed ID: 25495750
[TBL] [Abstract][Full Text] [Related]
18. Trisubstituted isoalloxazines as a new class of G-quadruplex binding ligands: small molecule regulation of c-kit oncogene expression.
Bejugam M; Sewitz S; Shirude PS; Rodriguez R; Shahid R; Balasubramanian S
J Am Chem Soc; 2007 Oct; 129(43):12926-7. PubMed ID: 17918848
[No Abstract] [Full Text] [Related]
19. Benzothiazole hydrazones of furylbenzamides preferentially stabilize c-MYC and c-KIT1 promoter G-quadruplex DNAs.
Pany SP; Bommisetti P; Diveshkumar KV; Pradeepkumar PI
Org Biomol Chem; 2016 Jun; 14(24):5779-93. PubMed ID: 27021281
[TBL] [Abstract][Full Text] [Related]
20. A newly identified G-quadruplex as a potential target regulating Bcl-2 expression.
Sun H; Xiang J; Shi Y; Yang Q; Guan A; Li Q; Yu L; Shang Q; Zhang H; Tang Y; Xu G
Biochim Biophys Acta; 2014 Oct; 1840(10):3052-7. PubMed ID: 25086254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
